A
Applied Therapeutics, Inc. (APLT)
NGM – Real vaqt narxi. Valyuta: USD
0.10
+0.10 (0.00%)
Yopilishda: Feb 2, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NGM – Real vaqt narxi. Valyuta: USD
0.10
+0.10 (0.00%)
Yopilishda: Feb 2, 2026, 4:00 PM EDT
Applied Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda yuqori tibbiy ehtiyojlarga ega bo'lgan ko'rsatmalarda tasdiqlangan molekulyar nishonlarga qarshi yangi mahsulot nomzodlari qatorini ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy mahsulot nomzodi AT-007 bo'lib, u sog'lom ko'ngillilar va kattalarda galaktozemiya davolash uchun 3-bosqichini, bolalarda galaktozemiya davolash uchun pediatrik klinik tadqiqotini, sorbitol dehidrogenaza fermentini davolash uchun va fosfomannomutaza fermenti-CDGni davolash uchun yakunlagan. U diabetic kardiomiopatiya, shuningdek, diabetik periferik neyropatiya davolash uchun 3-bosqich klinik sinovlarida bo'lgan AT-001ni, shuningdek, diabetik retinopatiyani davolash uchun preklinik tadqiqotlarda bo'lgan AT-003ni ishlab chiqadi. Kompaniya AT-007ni o'z ichiga olgan dori vositalarini tijoratlashtirish uchun Mercury Pharma Group Limited bilan eksklyuziv litsenziya va ta'minot shartnomasiga ega. Applied Therapeutics, Inc. 2016-yilda tashkil etilgan va Nyu-York, Nyu-Yorkda joylashgan. 2026-yil 3-fevral holatiga ko'ra, Applied Therapeutics, Inc. Cycle Group Holdings Limited sho'ba korxonasi sifatida faoliyat yuritadi.
| Ism | Lavozim |
|---|---|
| Dr. Evan Prescott Bailey M.D. | Chief Medical Officer |
| Dr. Todd F. Baumgartner M.D., M.P.H. | Chief Regulatory Officer |
| Mr. Constantine Chinoporos | COO & Chief Business Officer |
| Mr. Corwin Dale Hooks | Chief Commercial Officer |
| Mr. Les D. Funtleyder | Interm CEO, CFO, Principal Financial Officer & Director |
| Ms. Catherine Thorpe | Interim Chief Accounting Officer |
| Ms. Dottie Caplan | Executive Vice President of Patient Advocacy & Government Affairs. |
| Ms. Reena Thomas Colacot | Head of Quality |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-02-03 | 8-K | d93556d8k.htm |
| 2026-01-30 | SC 14D9/A | d304483dsc14d9a.htm |
| 2026-01-29 | SC 14D9/A | d47308dsc14d9a.htm |
| 2026-01-28 | SC 14D9/A | d38093dsc14d9a.htm |
| 2025-12-29 | SC 14D9 | d84762dsc14d9.htm |
| 2025-12-12 | SC14D9C | d593019dsc14d9c.htm |
| 2025-11-20 | 8-K | aplt-20251120.htm |
| 2025-11-13 | 8-K | aplt-20251109.htm |
| 2025-08-29 | 8-K | aplt-20250829.htm |
| 2025-08-14 | 8-K | aplt-20250813.htm |